{"data":{"id":"us/42-cfr-52a.8","jurisdiction":"us","citation":"42 CFR 52a.8","heading":"a.8 Other HHS regulations and policies that apply.","body":"Several other regulations and policies apply to this part. These include, but are not necessarily limited to:\n2 CFR parts 200 and 300—Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.\n42 CFR part 50, Subpart A—Responsibilities of PHS awardee and applicant institutions for dealing with and reporting possible misconduct in science\n42 CFR part 50, Subpart D—Public Health Service grant appeals procedures\n42 CFR part 50, subpart F—Responsibility of applicants for promoting objectivity in research for which PHS funding is sought\n45 CFR part 16—Procedures of the Departmental Grant Appeals Board\n45 CFR part 46—Protection of human subjects\n45 CFR part 76—Governmentwide debarment and suspension (nonprocurement) and governmentwide requirements for drug-free workplace (grants)\n45 CFR part 80—Nondiscrimination under programs receiving Federal assistance through the Department of Health and Human Services—Effectuation of Title VI of the Civil Rights Act of 1964\n45 CFR part 81—Practice and procedure for hearings under part 80 of this title\n45 CFR part 84—Nondiscrimination on the basis of handicap in programs and activities receiving or benefiting from Federal financial assistance\n45 CFR part 86—Nondiscrimination on the basis of sex in education programs and activities receiving or benefiting from Federal financial assistance\n45 CFR part 91—Nondiscrimination on the basis of age in HHS programs or activities receiving Federal financial assistance\n45 CFR part 93—New restrictions on lobbying\n59 FR 14508 (March 28, 1994)—NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research.\nNote:\nThis policy is subject to change, and interested persons should contact the Office of Research on Women's Health, NIH, Room 201, MSC 0161, BETHESDA, MD 20892-0601 (301-402-1770; not a toll-free number) to obtain references to the current version and any amendments.\n59 FR 34496 (July 5, 1994)—NIH Guidelines for Research Involving Recombinant DNA Molecules.\nNote:\nThis policy is subject to change, and interested persons should contact the Office of Recombinant DNA Activities, NIH, Suite 323, 6000 Executive Boulevard, MSA 7010, BETHESDA, MD 20892-7010 (301-496-9838; not a toll-free number) to obtain references to the current version and any amendments.\nPublic Health Service Policy on Humane Care and Use of Laboratory Animals, Office of Laboratory Animal Welfare, Office of Extramural Research, NIH (Revised September 1986).\nNote:\nThis policy is subject to change, and interested persons should contact the Office of Laboratory Animal Welfare, Office of Extramural Research, NIH, Rockledge 1, 6705 Rockledge Drive, Bethesda, Maryland 20817, telephone 301-594-2382 (not a toll-free number) to obtain references to the current version and any amendments.","path":["Title 42—Public Health","CHAPTER I—PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—GRANTS","PART 52a—NATIONAL INSTITUTES OF HEALTH CENTER GRANTS"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-42.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:26:11Z","sha256":"217dfa0f240f39e48bd48816657a2b7a559570c3b8091ebb247ecd1b1cc18995","source_id":"us-cfr","stale":true,"prev":"us/42-cfr-52a.7","next":"us/42-cfr-52a.9"},"notice":"GroundRules: Original legal text. Not legal advice."}